Christopher Blanchette

Christopher Blanchette, PhD, MBA, currently serves as Vice President of Clinical Data Science & Evidence and holds several other leadership positions at Novo Nordisk, where tenure began in November 2018. In addition, Christopher is the Chair-elect of the Industry Council at ISPOR, an Associate Editor for the Pharmacoepidemiology section at Frontiers, and has held adjunct professorships at multiple universities including Rutgers University and Saint Joseph's University. Christopher's previous experience includes roles at Ipsos Healthcare and Precision Health Economics and a research health scientist position with the U.S. Department of Veterans Affairs. Academic qualifications include a PhD in Pharmaceutical Health Services Research and an MBA in Pharmaceutical & Healthcare Marketing, among other degrees from prestigious institutions.